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Abstract
Background: Exactly how human tumors grow is uncertain because serial observations are impractical. One approach to
reconstruct the histories of individual human cancers is to analyze the current genomic variation between its cells. The
greater the variations, on average, the greater the time since the last clonal evolution cycle (‘‘a molecular clock hypothesis’’).
Here we analyze passenger DNA methylation patterns from opposite sides of 12 primary human colorectal cancers (CRCs) to
evaluate whether the variation (pairwise distances between epialleles) is consistent with a single clonal expansion after
transformation.
Methodology/Principal Findings: Data from 12 primary CRCs are compared to epigenomic data simulated under a single
clonal expansion for a variety of possible growth scenarios. We find that for many different growth rates, a single clonal
expansion can explain the population variation in 11 out of 12 CRCs. In eight CRCs, the cells from different glands are all
equally distantly related, and cells sampled from the same tumor half appear no more closely related than cells sampled
from opposite tumor halves. In these tumors, growth appears consistent with a single ‘‘symmetric’’ clonal expansion. In
three CRCs, the variation in epigenetic distances was different between sides, but this asymmetry could be explained by a
single clonal expansion with one region of a tumor having undergone more cell division than the other. The variation in one
CRC was complex and inconsistent with a simple single clonal expansion.
Conclusions: Rather than a series of clonal expansion after transformation, these results suggest that the epigenetic
variation of present-day cancer cells in primary CRCs can almost always be explained by a single clonal expansion.
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Introduction
Human cancers, such as colorectal cancers, are often relatively
symmetric masses of tumor cells (Figure 1). They likely start from a
single transformed cell, but how the progeny of this first cell
eventually grow into a visible tumor is uncertain. One of the most
fundamental characteristics of a human cancer, the number of cell
divisions since transformation, or tumor ‘age’, is not directly
measurable. For a long time we have understood that for solid
tumors, a single transformed cell seeds the growth, and that
present-day tumor cells are descendants from a clonal expansion
of the first malignant cell [1]. Under such a growth model, the
time to the most recent common ancestor of the cancer cell
population is a measure of tumor age. This suggests the use of
molecular phylogeny for inferring the tumor’s past. Phylogenies
are commonly used to estimate the time to the most recent
common ancestor of related populations. Using molecular
phylogeny to reconstruct the tumor’s past will allow us to address
basic questions about the unique histories of human cancers.
A common approach for developing phylogenies is the
comparison of DNA sequence variation among different groups
of organisms. However, within a human cancer, genetic variation
due to somatic cell mutation is sufficiently rare that it is impractical
to study. Instead, we focus on the epigenetic variation of DNA
methylation [2]. DNA methylation is copied during somatic cell
division and passed from generation to generation, with replication
error (epigenetic ‘drift’). The differences in DNA methylation
patterns that are introduced in the daughter cells record
information on numbers of cell division. Since daughter cells are
adjacent cells they should be the most similar in terms of
epigenetic variation. At the same time, because a tumor is an
expanding population, progeny move apart and cells on opposite
halves of the tumor are likely only to be related near the initial
growth phase in the distant past, so that their DNA methylation
patterns should be the most distinct. Siegmund et al. (2009) [3]
showed that by sampling cells from multiple locations in a
colorectal tumor and combining information on epigenetic
distance with physical distance, they could infer a tumor’s
ancestry.
Physically, colorectal adenocarcinomas are comprised of glands
that provide a natural substructure for (epi)genome sampling. By
sampling multiple DNA sequences, from multiple glands in both
the left and right side of the tumor, epigenetic distance can be
computed between cells for three different physical distances:
within a gland, between glands within a cancer half, and between
glands from opposite cancer halves (see Figure 2). Using this
approach, Siegmund et al. [3] observed smaller epigenetic
distances within cancer glands than between glands, supporting
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than cells from different glands. They also found that for the
majority of their colon cancers, epigenetic distances between
glands are similar for glands sampled from opposite tumor halves
and for glands sampled within the same tumor half, leading the
authors to conclude that many cancers undergo a rapid initial,
‘‘homogenizing’’ expansion and that cancers are ‘‘flat’’ [3,4].
However, in a subset of cancers where they observed smaller
epigenetic distances within tumor half than between tumor half,
they were unable to get a good fit of their growth model.
Consequently, we are interested in evaluating different models for
tumor growth that would allow for this alternate behavior.
Specifically, we are interested in how variations in tumor physical
growth may produce asymmetries in the epigenetic distances
between tumor cells.
Recent mathematical models for cancer growth focus on modeling
single-cell behavior [5,6,7]. Our methodology is a model for cell
ancestry that could be super-imposed on any single-cell model that
simulates cell division. The tumor growth model we simulate is for a
single clonal expansion, applying a constraint on the total number of
cells. The models we consider are outlined in Figure 1. A tumor may
grow uniformly, either quickly or slowly. Alternatively, there may be
differences in division rates between tumor sides, such that one side
has a different mitotic age. Tumor growth is modeled as a
combination of two processes: one for cell division, and one for gland
division [3]. An original transformed cell divides exponentially
through a doubling process until it reaches sufficient numbers to
populate a gland. As the cells cont i n u et od o u b l ei nn u m b e r ,t h e
glands also divide, so that the maximum number of cells allowed in a
gland is not exceeded. We put a constraint on the total number of
glands in the tumor, which we estimate based on the physical size of a
tumor. Glands stop dividing when they reach this maximum number.
In Siegmund et al. [3], the model for gland division is divided into two
phases, one for exponential growth (during the cell doubling phase),
and one for no growth. During this latter phase, the cells continue to
dividewithinthe glands,but celldeath startsto occur allowing the total
number of cells to remain constant. Although this two-phase model for
gland division is a useful approximation for how a tumor might grow,
a smooth growth trajectory is likely more realistic. In this paper, we
model gland division using a Gompertzian, S-shaped growth curve
(see Figure 3). A Gompertz growth curve is more flexible, allowing us
to slow down the growth rate during the early phase of tumor
development, and eliminate the discontinuity of a transition between
exponential growth and no growth. This slowing down of the initial
growth period might introduce the extra epigenetic variation seen in a
subset of tumors. Alternatively, extra epigenetic variation may appear
from asymmetric growth where tumor sides have different mitotic
ages. Through a simulation study, we propose to assess the effect of
different Gompertzian growth models, both symmetric and asym-
metric, on the patterns of epigenetic tumor variation.
Results
Colon Cancer Data
Figure 2 shows data for one colon cancer. The measure of
epigenetic distance increases with physical distance between the
tags analyzed. The average Hamming distances are 0.62, 1.24 and
Figure 1. A picture of a colorectal adenocarcinoma with a cartoon illustrating three possible growth models: rapid growth, gradual
growth, asymmetric growth.
doi:10.1371/journal.pone.0012002.g001
Figure 2. Tumor sampling scheme with bisulfite sequence data
generated from one colorectal tumor. Grey circles denote cancer
glands. Six to seven glands are sampled from each tumor half and
multiple clones are sequenced for each tumor gland (e.g. 7–8). Black
circles denote methylated CpGs and white circles unmethylated CpGs.
Three physical distances: within a cancer gland, between cancer glands
from the same tumor half, and between cancer glands from opposite
tumor halves.
doi:10.1371/journal.pone.0012002.g002
Inferring Tumor Ancestry
PLoS ONE | www.plosone.org 2 August 2010 | Volume 5 | Issue 8 | e120021.34, respectively, comparing tags within glands, tags within tumor
halves (but between glands), and tags between tumor halves. This
cancer is an example of a ‘‘flat’’ tumor, where we find similar
distances between glands both within and between tumor halves.
This suggests a rapid clonal expansion, such that all present-day
glands are equally distantly related through the early, ancestral
glands.
Figure 4 displays the average Hamming distances by tumor half
for all twelve tumors. The within-gland distances for a tumor are
denoted by G and the within-half distances by H. Lines connect
the distances from the same tumor. For all tumors, the average
within-gland distance is smaller than the average within-half
distance, as reported by Siegmund et al. [3], suggesting that cells
within a gland are more closely related than cells from different
glands. Lines that lie close to the diagonal show within-gland
distances and within-half distances that are similar in the left and
right halves. This pattern is expected from tumors that underwent
a similar numbers of cell division in each tumor half (‘‘symmetric
growth’’). Lines that fall off of the diagonal show the average
Hamming distance is higher in one tumor half. (We arbitrarily
assign the larger distance to the left half.) This pattern suggests that
the tumors grew asymmetrically and that one half underwent more
cell division than the other. The eight ‘‘flat’’ colorectal tumors with
a between-half distance similar to a within-half distance are
denoted by solid lines. The remaining four are denoted by broken
lines. Because of the correlation structure of the data (all cells
descend from a common ancestor), we are unable to assign
statistical significance to a test for symmetric growth. Therefore we
investigate, through simulation, various models that will allow us
to observe different patterns of epigenetic variation, and
characterize how variable those patterns can be. We begin with
a thorough exploration of models undergoing symmetric growth,
exploring the effect of the rate of tumor growth (slow versus fast),
and consider at the end the variation in patterns that can be
induced if growth is asymmetric.
Symmetric Growth
Fraction of tumor sampled. First, we evaluate whether the
sizes of the tumor samples affect our measure of epigenetic
distance, the average Hamming distance. Figure 5a shows a
schematic that illustrates our model for sampling glands from
tumor halves. By restricting the size of the cancer fragment from
which we sample the glands, we obtain some control over the time
to the most recent common ancestor of the sampled glands. The
smaller the size of the initial cancer fragment, the more recent is
the time at which the sampled glands coalesce to a common
ancestor. And the more recent the common ancestor, the smaller
the epigenetic distance between glands becomes (Figure 5b). In
order to mimic sampling from opposite tumor halves, we sample
from the top-most and the bottom-most branches of the tree.
Figure 5b shows the three mean estimates of the average
Hamming distance from a simulation study, when sampling
glands from different fractions of the tumor in each half. First, we
see that the mean estimates of average Hamming distance increase
with physical distance in the tumor (within-gland,within-
half,between-half). Neither the within-gland distances nor the
between-half distances are sensitive to the size of the cancer
fragment from which we draw our samples, but the within-half
distance is. The distance decreases the smaller the fraction of
tumor sampled. The within-half distance is also sensitive to the
rate of tumor growth. The slowing down of tumor growth has the
intended effect of decreasing within-half distance compared to
between-half distance. This is most apparent when studying small
cancer fragments.
In our study, the two experimentally sampled cancer fragments
represent 5% or more of the total tumor volume. Figure 5b shows
little difference in within-half and between-half distances for
cancer fragments of this size. Nevertheless, we sample from the
Figure 3. The number of glands in a tumor as a function of the
number of generations of cell division for Gompertzian growth
models with inflection times of 49 and 320 generations and a
maximum of 524,288 glands.
doi:10.1371/journal.pone.0012002.g003 Figure 4. Average Hamming distance by tumor half for the 12
tumors published by Siegmund et al. [3] The x-axis represents the
distance in the right tumor half and the y-axis the distance in the left
tumor half. Within-gland distances are denoted by G and within-half by
H. Lines connect the pairs (G,H) from the same tumor. The line type
indicates differences in distance between-half and within-half (BH-WH).
Solid lines denote small BH-WH differences (difference ,0.1, 8 ‘‘flat’’
tumors) and broken lines denote larger differences (BH-WH difference
.0.4, 4 tumors). The type of broken line indicates WH differences
between left and right tumor half; dotted lines indicate tumors with
large WH differences (.0.6, 3 tumors); the dashed line indicates one
tumor with small WH difference (0.14).
doi:10.1371/journal.pone.0012002.g004
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(2.5% per half) in order to maximize our chances of seeing smaller
within-half than between-half distances for slow-growing tumors.
Epigenetic distances under different growth models. We
simulate data for tumors having different growth rates, models for
cell division, and numbers of cancer stem cells (CSCs) at various
stages of their development (numbers of generations of cell
division) and plot the average estimates for the three different
epigenetic distances: between half (BH), within half (WH) and
within gland (WG) for various parameter settings (Figure 6).
Focusing first on the estimate of BH distance and comparing
results in the right column to results in the left column, we see that
the BH distance is higher at 700 generations of cell division than at
100 generations. In fact we see a general trend of increasing BH
distance with increasing number of cell divisions through 1000
generations (results not shown). Looking within a column at
models for tumors of the same age, the average BH distance does
not vary by number of CSCs (slope=0) or the type of cell division
and tumor growth rate (constant intercept). These suggest that for
a symmetric tumor and known DNA methylation error rates, the
tumor’s age is estimable using the information on between-half
distance alone.
In contrast, the estimate of within-gland distance is a function of
multiple parameters. WG distance increases with tumor age when
there are multiple CSCs seeding a cancer gland. This behavior
reflects the epigenetic drift occurring to the CSCs. If there is a
single CSC seeding a gland, all non-CSCs are closely related
resulting in little epigenetic variation between epialleles within a
gland. Drift in the DNA methylation pattern of the long-lived CSC
has a negligible effect on the within-gland distance. However, if a
gland has two (or more) long-lived CSCs that drift apart from one
another over time, the descendants of each will have epigenetic
patterns similar to their ancestral cell, and will show differences
from the descendants of the other CSC. On average, the number
of differences increases with the number of divisions separating the
CSCs, resulting in an increased WG distance with increased tumor
age. Siegmund et al. [3] reported this behavior for their data,
supporting a model for multiple CSCs.
For a tumor of a given age, two parameters influence the within-
gland distance: the number of CSCs and the type of cell division
(deterministic or probabilistic). These two parameters are not
identifiable from the WG distance alone. Compared to growth
under a deterministic model for cell division, a probabilistic model
with a higher numbers of CSCs will yield similar WG distance
estimates. The growth rate is also seen to play a role, but only
under the deterministic model for cell division; under the
deterministic model, higher WG distances are seen under faster
growing tumors. Under a model for probabilistic cell division, the
WG distance appears to be insensitive to the tumor growth rate.
Lastly, we report on the within-half distance, and for which
scenarios it is most different from between-half distance. The
largest differences in mean estimates of the WH and BH distances
occur for slow growing tumors that are both young (have not
achieved their maximum size), and have only a few to moderate
number of CSCs. If the majority of cells are CSCs, there is a lot of
diversity even within a tumor half such that the within-half
distances are just as large as the between-half distances. Also, as
the tumors age, the WH distance approaches the BH distance, and
by the time the tumor is full grown, even for the slow-growing
tumor with few CSCs, the two distances are approximately equal
for our sampling design. This suggests that a slower Gompertzian
growth rate cannot account for the larger BH-WH distances that
we observe in four of our tumors (differences=0.47, 0.68, 0.80,
1.63), and motivates us to explore whether asymmetric growth,
where one tumor half undergoes more generations of cell division
than the other, could explain such differences.
Asymmetric growth
Under asymmetric growth, we expect the within-half distance to
differ in the two tumor halves, and the between-half distance to be
greater than the average within-half distance, and more similar to
the within-half distance from the faster-growing half. We
investigate this possibility by simulating tumors which undergo
different numbers of cell division in their two halves. First, we
determine if larger BH than WH distances can arise under
asymmetric growth. Second, we evaluate the variability in WH
distances between left and right tumor half, under both symmetric
and asymmetric growth models. For the latter scenario, we
simulate data for 1,000s of tumors under a symmetric growth
model and compute the (absolute) difference in WH distance
between left and right tumor half to assess normal variation. The
95
th percentile from this distribution is used to infer asymmetric
growth for a tumor with an observed difference that exceeds this
value. The power of the test is assessed from simulations of tumors
that grow asymmetrically.
BH-WH distances. We simulate 100, 400, and 700
generations of cell division in each tumor half under the
probabilistic survival model, fixing the number of CSCs per
gland at 128 and 1024. One thousand replicate data sets are
generated for each scenario.
On average, the difference between the between-half and the
within-half distances is greater under asymmetric growth than
under symmetric growth. For this we compare tumors that have
Figure 5. The relationship between physical proximity in the
tumor and epigenetic distance. (a) The relationship between the
fraction of tumor sampled and time to the most recent common
ancestor. (b) Mean estimates of average Hamming distance for three
physical distances: between tumor half (BH), within tumor half (WH) and
within gland (WG) under different growth curve inflection times
(inflection time is 49 for figure on left and 320 for figure on right)
(N=10,000 replicates).
doi:10.1371/journal.pone.0012002.g005
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e.g. 100 and 700 generations in the left and right half, respectively,
compared to 400 generations in each half, for a total in each
tumor of 800 generations. The median BH-WH difference for the
tumors under asymmetric growth is 0.45 (95% simulation interval
(SI)=0.09–1.0) under 128 CSCs and 0.44 (95% SI=0.21–0.80)
under 1024 CSCs. These are greater than the differences under
symmetric growth (see Figure 6). Furthermore, these differences
are large enough to explain the four ‘‘non-flat’’ tumors. Next we
investigate the variation in within-half distances between left and
right tumor halves.
Left – right WH distances. We assess asymmetric growth by
comparing the absolute difference in WH distance in the left and
right tumor half to the upper bound (95
th percentile) of the
distribution under a symmetric growth model. Under symmetric
tumor growth, the absolute difference of the WH distance
increases with increasing numbers of generations. For 1024
CSCs, the 95
th percentiles of the absolute differences are 0.552,
0.606, and 0.613 for 100, 400, and 700 generations, respectively.
This suggests that an absolute difference in Hamming distance
greater than about 0.6 is needed to suggest asymmetric growth. As
expected, the degree of asymmetry of tumor growth dictates how
Figure 6. Mean estimate of average Hamming distance between-half (BH), within-half (WH), and within gland (WG) from a
simulation study (N=10,000 replicates). Growth curve inflection time is 49 generations of cell division for fast growing tumors and 320
generations for slow-growing tumors.
doi:10.1371/journal.pone.0012002.g006
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100 generations and the second undergoes 700 generations, all
1,000 simulated tumors had an average (absolute) difference in
WH distance that exceeded 0.6. However, if the tumor halves are
more close in age (400 and 700 divisions), this much variation is
relatively rare (19%). If there are fewer CSCs, more variation
between the two halves is observed (left-right WH
difference=0.863, 0.987, and 1.018, respectively). Under this
model, tumors that show a WH difference greater than 1.0 would
show evidence for asymmetric growth.
Two tumors show variation between tumor halves exceeding
the more stringent criteria of 1.0 for concluding asymmetric
growth (Figure 4). These are the points labeled as H appearing in
the upper left triangle of Figure 4, where the difference between
the y-axis and x-axis coordinates exceeds one. Using the less
stringent criteria of 0.6, five tumors show variation between tumor
halves exceeding random variation (WH difference .0.6, points H
appearing in both the white and light grey area). Three of these
five tumors also show large BH-WH differences (.0.4) (Figure 4,
dotted lines). Although two tumors do not, this is not surprising
given the wide 95% simulation intervals reported earlier under
asymmetric growth models and suggests a lack of power to detect
asymmetric growth. Together, these results suggest that as few as
two, but as many as five of the tumors may show evidence of
asymmetric growth.
Discussion
Reconstructing tumor histories from epigenomic variation may
be difficult if outcomes are highly sensitive to small variations in
tumorgrowth,orifunderlyingancestriesarecomplex.Forexample,
methylation patterns may be extremely complex if primary CRCs
grow through sequential clonal evolution because each clonal
expansion would have a different mitotic age and diversity.
However, experimental data from human CRCs reveal that
passenger DNA methylation pattern variation from different parts
of the same tumor are often similar [3], suggesting underlying
ancestries may be limited to relative symmetric growth patterns (i.e.
single clonal expansions). Biologically, it is unlikely that tumors will
grow perfectly symmetrical as some parts of the same tumor are
likely to growfaster than others due to different microenvironments.
We investigated this potential problem by modeling how different
tumor growth rates effect methylation pattern variation. The model
for tumor growth allows cancer glands to divide following a smooth,
Gompertzian growth curve. Under a Gompertzian model, the rate
of tumor growth is parameterized by the time of the maximum
growth rate (inflection time). We consider two extremes of this
model.Onthe one extremewehavea fast-growingtumorwherethe
initial growth is constrained such that it will not grow faster than a
doubling of cancer glands at each generation (exponential growth).
On the opposite extreme, we pick a more slow-growing tumor,
where the tumor grows to within 5% of its maximum size by a fixed
number of generations. In order to maximize our chances for
finding differences in epigenetic distances within a tumor half and
between tumor halves, we sampled from the extreme 5% of our
cancer tree, the smallest cancer fragment size that is likely to
represent real tumor fragments.
In simulations, we find that regardless of the rate of tumor
growth, for tumors that have achieved their maximum size, at least
approximately, WH distance<BH distance. This is consistent with
what we observe in eight of our tumors. In another three tumors,
differences between WH and BH distance may be attributed to the
asymmetric growth of the two tumor halves, albeit sequential
clonal evolution could also explain how passenger methylation
patterns may differ between tumor halves. Then the data from
only one tumor cannot be explained by our model. These
simulation studies help explain why experimentally obtained DNA
methylation pattern data typically reconstruct symmetrical tumor
growth, because epigenomic variation is relatively insensitive to
growth rates or regional differences in growth rates. Although the
simulations illustrate that detailed information on tumor growth
will be difficult to infer from tumor methylation patterns, this
drawback should be tempered by current absence of methods to
infer human tumor histories.
The inability to model all tumors is evidence for further
dependencies in our data that are not captured by our model,
including experimental problems with adequately sampling
epialleles from human tumors. Such dependencies would allow
for greater variation in the data we observed, perhaps permitting
us to see larger differences between WH and BH distances. As a
next step, we propose to relax the assumption that all CpG sites
are methylated independently of one another. In fact, one study
has found that DNA methylation errors are more likely to be
added to tags that have a lot of DNA methylation present [8].
Unfortunately the data in this study is not sufficient to explore
different dependence structures. A similar conclusion was reached
in a second study [9], however their analysis did not take into
account the mixture of alleles that arises when studying autosomal
loci. We are in the process of obtaining new bisulfite sequence data
from cell lines which will allow us to investigate different models in
detail. Our future work will be to focus on better understanding,
and modeling of the DNA methylation copy errors.
Several investigators have proposed single-cell models for tumor
growth [6,7,10]. Like their models, our model mimics actual cell
division. Unlike their models, ours provides estimates of tumor age
and number of dividing cells for individual tumors. These
estimates are obtained using approximate Bayesian computation,
a simulation-based approach [2,11]. Our data are inconsistent
with a recent report suggesting that tumors are conglomerates of
self-metastases [7]. Such a sequential growth pattern would likely
generate greater heterogeneity in epigenomic variation than we
observe in our data, with older tissue sections showing greater
diversity than more recent conglomerates. Instead, we find that the
majority of our tumors appear ‘‘flat’’, with similar measures of
diversity in the outermost left and outermost right tumor sides.
Such behavior can be explained by a single clonal expansion.
In our model there are six parameters, two of which are the
probabilities that DNA methylation copy errors occur at a given
CpG site (methylation and demethylation errors). In these types of
models, the estimates of DNA methylation copy errors and the
total number of generations of cell division are not identifiable. For
a given set of data (and parameters), similar data can be generated
after a doubling of the copy error rates and halving of the number
of generations. Siegmund et al. [3] suggested specifying an average
tumor from a set of tumors, and calibrating the error estimates to
agree with that average. For the sake of focusing this paper, we do
not address this issue further here. Instead, we fix the DNA
methylation copy error rates at plausible values for the BGN locus,
and evaluate the effect of other parameters on our data. In
practice, we will estimate the copy error rates from the data by a
proper calibration.
Other simplifications we have made to the model is to assume
non-overlapping generations. Inclusions of overlapping generations
is conceptually straightforward and will be explored in future work.
In conclusion, we present a biologically plausible model that
allows us to explore the unobserved ancestries of human CRCs.
Experimental data constrains our modeling such that a single
clonal expansion after transformation is usually sufficient to
Inferring Tumor Ancestry
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parts of the same primary CRC. Further studies with more data
may better reconstruct exactly how individual human tumors
grow.
Materials and Methods
Colon cancer data
In Siegmund et al. (2009), bisulfite sequence data was generated
for two X chromosomal regions in tumors from 12 male patients.
Restricting the study to male patients simplifies the statistical
analysis because in males, cells only carry one copy of the X
chromosome. Therefore, the cell that underwent the initial
transformation to cancer carried a single X chromosome and all
X chromosomes in the cancer are descendants from that original
copy. Bisulfite sequence data were obtained from sampling six or
seven glands each from opposite tumor halves (see Figure 2). The
glands are sampled from cancer fragments that are a minimum of
2 cm apart. Cancer glands contain ,2,000–10,000 cells, and eight
clones are sequenced from each gland. In this paper we focus on
data for 9 CpG sites sequenced in the Byglycan (BGN) region. The
data for a single site are coded 0–1, where ‘‘1’’ denotes methylated
and ‘‘0’’ unmethylated. A ‘tag’ refers to the code for a string of CpG
sites. An unmethylated tag is represented by ‘‘000000000’’. When
studying n CpGs, there are a total of 2
n possible tags.
This study was approved by the Institutional Review Board of
the University of Southern California Keck School of Medicine.
Written informed consent was obtained from all study partici-
pants.
Data simulation
Growth model. Tumor growth is modeled by two branching
processes. We specify a model for cell division that is nested within a
model for tumor glands. For both processes, we assume, for
convenience, that the generations are discrete; however, this
assumption can be relaxed and overlapping generations
permitted. The entire process follows a tree topology similar to
theone shown inFigure 7a. In Figure 7a, time runs from lefttoright
across the page, with the left-most cell being the original
transformed cell from which the others grow. In an initial growth
phase, the original transformed cell undergoes a period of
exponential growth (cell doubling) until it forms a small
population that comprises a cancer gland. In subsequent
generations, the two growth processes (cellular and glandular)
occur simultaneously. The number of cancer glands follows a
Gompertzian growth model, a smooth S-shaped curve. At
generation k, the number of glands, Nk, is given by
Nk~Nmax   exp {exp {Gk {ko ðÞ ðÞ ðÞ ,
where Nmax is the maximum number of glands and is estimated
based on tumor size, G is the growth rate, and ko is the inflection
time point, or the time of maximum growth. For any inflection time
point ko, we can estimate the growth rate G, by substituting Nk=1
at generation k=1. Earlier research suggests that there are
approximately one billion (10
9) cells per cm
3 of tumor and 8,192
cells per gland. To simulate tumors that are approximately 4 cm
3 in
size, we set as a maximum 524,288 glands (524,288 glands68,192
cells/gland ,4.3610
9 cells). Figure 3 shows examples of growth
curves that could generate, after 700 generations, a tumor with ,K
million glands. The possible Gompertzian growth models are
restricted so that the growth rate never results in more than a
doubling of the number of cancer glands in any single generation.
Therefore,a fast-growingtumorwill approximatelydoubleinsize at
each generation during its early development, before slowing down
Figure 7. Schematic of sample genealogy. (a) Example genealogy. Black circles denote cancer stem cells and grey circles denote cancer glands.
(b) Two models for cell division. Black circles denote CSCs and white circles denote non-CSCs.
doi:10.1371/journal.pone.0012002.g007
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(solidline Figure3).Aslow-growingtumorwill startoffslowly,never
doubling in size at any single generation, but growing along a
smooth S-shaped curve, until attaining the fixed maximum size. In
Figure 3, the inflection time for the slow-growing tumor (dashed
line) is chosen so that the tumor will be within 5% of its maximum
size at 700 generations.
During the Gompertzian growth phase, individual cells acquire
different behavior. Some continue to divide with unlimited
proliferative potential while others divide, but for only a fixed
number of generations. We refer to the former cell type as cancer
stem cells (CSCs) and the latter as non-cancer stem cells. Allowing
for cells with different behavior, allows the cells to continue ‘aging’
in a tumor of a fixed size. We fix the number of CSCs and non-
CSCs to constants for all glands in a tumor. These represent the
average number of CSCs and non-CSCs, taken across all glands.
One possible extension of our model would include the variability
in these numbers across glands to capture random fluctuations.
At each generation cells divide, however the manner in which
they divide will depend on whether the gland divides, or simply
‘ages’. If a gland divides, the cells divide producing two daughter
cells of the same type (e.g. a CSC produces two CSCs and a non-
CSC produces two non-CSCs). The number of cells in the gland is
doubled, and the offspring segregate at random as the gland
divides into two offspring glands. If the gland does not divide, the
cells follow a division process described in Figure 7b. The two
models considered allow the cells within a gland to continue to
‘age’, without growing in number. In the deterministic model
CSCs divide asymmetrically, always leaving one CSC and one
non-CSC as daughter cells. In the probabilistic model, CSCs
divide either asymmetrically or symmetrically, each with 50%
probability. Symmetric divisions of a CSC into two CSCs or into
two non-CSCs are both given equal probability (25% each). This
probabilistic model for cell division has been used previously to
study stem cell behavior in normal colonic crypts [12].
Overall, there are six parameters in our model: (i) the inflection
time for the Gompertzian growth model, (ii) the total number of
generations of cell division, (iii) the number of CSCs per gland
(constraining the total number of cells in a gland to 8,192), (iv) the
type of cell division within a non-dividing gland (100% asymmetric
or 50%), and (v–vi) two DNA methylation copy error rates
(methylation and demethylation error rates). The details of the
simulation process and the modeling of DNA methylation copy
errors are described next.
Simulating the branching process. The simplest way to
simulate tumor growth is to model the entire branching process
and then randomly sample cells from the glands sampled in the
final generation. However, because a human tumor of moderate
size contains ,4.3 billion cells, this will surpass memory limits on
standard desktop computers. Consequently, we have adopted a
more efficient, genealogical perspective in which we model only
the ancestry of the sampled cells (drawn from the rightmost
generation in Figure 7a). First, we generate the shape of the
ancestry for the glands sampled from our final generation (e.g. 14
glands); then we simulate the evolution of the cell populations
along that ancestry. The details follow:
1. For each generation k, we estimate the number of glands Nk
from the Gompertz equation, storing the entire ancestry for all
glands. Although the order of branches for the division of any
single gland is symmetric, the glands from the top of the tree
will be more similar to one another than they will to glands
from the bottom of the tree, and vice versa, since glands from
the top and bottom are only related through their shared
ancestry back to the original ancestral gland. Thus, by
considering the top of the tree as one half of the tumor and
the bottom of the tree as the other half, we have created a local
similarity of glands from the same tumor half. To mimic the
sampling of glands from opposite halves of the tumor, we
restrict our sampling in the final generation to glands from the
top-most and bottom-most branches of the tree (e.g. In
Figure 7a, the top and bottom 2.5% of glands). Then we save
the ancestry for only the sampled glands.
2. Next we model the evolution of cells along the ancestry of our
sampled glands. First, we notice that we do not need to model
all cells in all generations because the CSCs are the only long-
lived cells in our tree. Since each gland must have the pre-
defined number of CSCs out of the total 8192 cells, the number
of non-CSCs can never be greater than 8192 less that number.
Furthermore, since a gland can never exceed the fixed total
number of cells, non-CSCs can never undergo more than 12
generations of division (see Table 1). Therefore we do not need
to generate non-CSCs in the early generations of our ancestry,
because they will not contribute to the population alive at the
end of tumor growth. We only generate non-CSCs in the final
n generations, where n depends on the number of CSCs (see
Table 1). For the early generations, we only need to simulate
data for the CSCs.
We begin by simulating the evolution of the first
transformed cell into the first cancer gland. Here we are
modeling a simple branching process for a haploid genome,
whereby at each generation k the cell copies itself from
generation k21, with possible changes in methylation status at
each locus (We discuss the details for the starting methylation
pattern and the way in which methylation status changes
below.) The first gland is formed when there are enough CSCs
cells to populate it. In each subsequent generation of growth,
cells divide in a manner that keeps the total number of CSCs
(and non-CSCs) per gland constant. As described earlier, if a
gland divides, all cells divide producing two daughter cells of
the same type and the offspring segregate at random as the
gland divides into two offspring glands. If the gland does not
divide, the cells follow a division process parameterized by r,
the probability of an asymmetric division as described in
Table 1. The maximum number of generations that non-
CSCs divide when there is a maximum of 8,192 cells per gland.
No. of CSCs No. of Generations Non-CSC divides
4096 0
2048 1
1024 2
512 3
256 4
128 5
64 6
32 7
16 8
89
41 0
21 1
11 2
doi:10.1371/journal.pone.0012002.t001
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appeal: (1) deterministic (immortal) cancer cell survival (r=1)
and (2) probabilistic (random) cancer cell survival (r=0.5).
Under the probabilistic model, a CSC has a 25% chance of
dividing into two CSCs and a 25% chance of dividing into two
non-CSCs, with a constraint of having a constant number of
CSCs in each generation. The constraint is implemented by
computing the probabilities of possible patterns for cell division
for any fixed number of CSCs. These joint probabilities are
determined by a convolution formula. At each generation the
CSCs are selected by sampling without replacement, condi-
tional probabilities are assigned, and the cell’s behavior is
determined. For example, if the required number of CSCs for
the next generation is reached, the remaining CSCs are forced
to yield non-CSC offspring only. For complete details on the
approach, see the supplemental information from [13].
For cancer, the DNA methylation pattern of the original
transformed cell is unknown. As our goal is to model tumor growth
from copy errors that accumulate with cell division, and because
most cancers occur in older individuals, the original transformed
cell is likely to have accumulated some baseline DNA methylation
levels. We simulate data for a single CpG region that includes 9
CpGs, assuming that 6 of the 9 measured CpGs are methylated in
the original transformed cell (,67%). We use this because it
represents the average global percent methylation seen in the
majority of our tumors. In future work, we will consider simulating
data over a variety of starting values to understand their effect on
the joint behavior of the summary statistics.
We model DNA methylation copy errors at each CpG
independently according to some constant probabilities. We
parameterize these with (m,d), where m denotes the probability
with which an unmethylated CpG becomes methylated and d the
probability with which a methylated CpG becomes unmethylated.
For these simulations, we fix these parameters at 0.001 and
0.00025, values that seem reasonable based on earlier analyses of
one of the X chromosomal regions (BGN). We expect that for
different regions of the genome the error rates will differ, and
extending these methods to multiple loci is an important direction
for future work. We focus in this paper, on the effects on our data
of the four remaining model parameters: (i) the inflection time
point for the Gompertzian growth curve (whether the tumor is fast
or slow growing), (ii) total number of cell divisions (tumor ‘age’),
(iii) the number of CSCs per gland, and (iv) the type of cell division
(deterministic or probabilistic).
Summary statistics
For any large data set, stochastic variation will make it
impractical to simulate data that replicate the exact DNA
methylation patterns we observe. Therefore, we assess our ability
to simulate data that mimic real data by a comparison of summary
statistics. Siegmund et al. found the average Hamming distance to
be the most informative parameter of tumor diversity [3].
Hamming distance is defined as the number of sites that differ
between two tags. For example, the distance between 0011 and
0110 is two. In a simulation study, we assess the impact of different
growth model parameters by their effect on the average Hamming
distance between tags sampled at three different physical distances:
within gland, between glands but within half, and between half.
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